120 related articles for article (PubMed ID: 1329732)
1. The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independently of receptor binding.
Sagan S; Charpentier S; Delfour A; Amiche M; Nicolas P
Biochem Biophys Res Commun; 1992 Sep; 187(3):1203-10. PubMed ID: 1329732
[TBL] [Abstract][Full Text] [Related]
2. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
[TBL] [Abstract][Full Text] [Related]
4. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of delta-opioid receptor selection by the address domain of dermenkephalin.
Charpentier S; Sagan S; Naim M; Delfour A; Nicolas P
Eur J Pharmacol; 1994 Jan; 266(2):175-80. PubMed ID: 8157070
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA
Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291
[TBL] [Abstract][Full Text] [Related]
7. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
8. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
9. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
10. Structural modifications of the N-terminal tetrapeptide segment of [D-Ala2]deltorphin I: effects on opioid receptor affinities and activities in vitro and on antinociceptive potency.
Schmidt R; Menard D; Mrestani-Klaus C; Chung NN; Lemieux C; Schiller PW
Peptides; 1997; 18(10):1615-21. PubMed ID: 9437724
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency.
Sagan S; Amiche M; Delfour A; Camus A; Mor A; Nicolas P
Biochem Biophys Res Commun; 1989 Sep; 163(2):726-32. PubMed ID: 2551274
[TBL] [Abstract][Full Text] [Related]
12. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints.
Naim M; Nicolas P; Baron D
Int J Pept Protein Res; 1996 May; 47(5):353-60. PubMed ID: 8791158
[TBL] [Abstract][Full Text] [Related]
13. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
Duchesne D; Naim M; Nicolas P; Baron D
Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402
[TBL] [Abstract][Full Text] [Related]
14. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue.
Heyl DL; Schullery SE; Renganathan K; Jayamaha MN; Rodgers DW; Traynor JR
Bioorg Med Chem; 2003 Aug; 11(17):3761-8. PubMed ID: 12901921
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
[TBL] [Abstract][Full Text] [Related]
16. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis.
Riand J; Baron D; Nicolas P; Benajiba A; Teng Y; Naim M
J Biomol Struct Dyn; 1999 Dec; 17(3):445-60. PubMed ID: 10636080
[TBL] [Abstract][Full Text] [Related]
17. Solution conformations of deltorphin-I obtained from combined use of quantitative 2D-NMR and energy calculations: a comparison with dermenkephalin.
Naim M; Nicolas P; Benajiba A; Baron D
J Pept Res; 1998 Dec; 52(6):443-56. PubMed ID: 9924989
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptors.
Misicka A; Cavagnero S; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
J Pept Res; 1997 Jul; 50(1):48-54. PubMed ID: 9273887
[TBL] [Abstract][Full Text] [Related]
19. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
20. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH
J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
